WBA - Walgreens Boots Alliance, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
66.48
-0.01 (-0.02%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close66.49
Open66.48
Bid65.15 x 800
Ask67.58 x 3200
Day's Range66.21 - 66.96
52 Week Range59.07 - 83.89
Volume4,609,632
Avg. Volume7,457,698
Market Cap65.976B
Beta0.88
PE Ratio (TTM)15.65
EPS (TTM)4.25
Earnings DateOct 23, 2018 - Oct 29, 2018
Forward Dividend & Yield1.76 (2.65%)
Ex-Dividend Date2018-08-17
1y Target Est71.05
Trade prices are not sourced from all markets
  • Moody's11 hours ago

    Rite Aid Pass-Through Trust, Series 1999-1 -- Moody's Places the CTL Rating of Rite Aid Pass-Through Trust, Series 1999-1 On Review For Possible Downgrade

    The rating was placed on review for possible downgrade due to the Rite Aid Corporation ("Rite-Aid") senior unsecured rating being placed on review for possible downgrade by Moody's on August 9, 2018. Rite-Aid was placed on review for possible downgrade due to Rite-Aid's announcement that it has terminated its merger agreement with Albertsons Companies, Inc. The merger termination leaves Rite-Aid in a weaker position as it lacks the scale or the balance sheet to compete in the changing pharmacy landscape with much larger and well capitalized competitors like CVS Health and Walgreens Boots Alliance, Inc. The ratings of Credit Tenant Lease (CTL) deals are primarily based on the senior unsecured debt rating (or the corporate family rating) of the tenants leasing the real estate collateral supporting the bonds.

  • Is Rite Aid Corporation a Buy?
    Motley Fool2 days ago

    Is Rite Aid Corporation a Buy?

    Another merger falls apart for Rite Aid. But could better days be ahead?

  • Why Walgreens Boots Alliance, Inc. Stock Popped 12.7% in July
    Motley Fool3 days ago

    Why Walgreens Boots Alliance, Inc. Stock Popped 12.7% in July

    The pharmacy chain rebounded after a steep drop in late June. Here's what investors need to know.

  • Strong Q2 2018 Results Cushion CVS Health’s Falling Share Price
    Market Realist4 days ago

    Strong Q2 2018 Results Cushion CVS Health’s Falling Share Price

    CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors. The company’s share price soared 6% during the day on August 8 before finally settling at $68.17, 4.2% higher than the previous day’s close.

  • Is Walgreens Stock an Attractive Bet?
    Market Realist4 days ago

    Is Walgreens Stock an Attractive Bet?

    As discussed in the previous section, six analysts have downgraded Walgreens Boots Alliance (WBA) since Amazon’s (AMZN) acquisition of PillPack in late June. As a result, Walgreens’s overall ratings have come down drastically. The company, which was rated 2.3 before the acquisition on June 28, is now ranked as a 2.7. Ratings are on a scale where one is a “strong buy,” and five is a “strong sell.”

  • TheStreet.com4 days ago

    Rite Aid Shareholders Cheer Merger Failure, Call on CEO to 'Put House In Order'

    proposed merger with Albertsons Companies, the stock price for the drug-store chain dropped 11.5% to $1.54 per share in Thursday trading. Some of the happiest people about the failed deal are its shareholders. Steve Krol, who owns 260,000 Rite Aid shares, was instrumental in making sure the deal fell apart.

  • Moody's4 days ago

    Rite Aid Corporation -- Moody's places Rite Aid's rating on review for downgrade following termination of merger with Albertsons

    Moody's Investors Service ("Moody's") today placed the ratings of Rite Aid Corporation (Rite-Aid) on review for downgrade including its Corporate Family Rating of B2 and its Probability of Default Rating of B2-PD. The review for downgrade is prompted by Rite-Aid's announcement that it has terminated its merger agreement with Albertsons Companies, Inc.

  • TheStreet.com5 days ago

    Rite Aid's Rotten Week: How Will It Now Compete Against Walgreens, CVS?

    Rite Aid had a horrid week. The stock has been pummeled by a spate of bad news, raising questions about how Rite Aid will continue to stack up against its competitors on pricing, footprint and innovation edge. The slide thus far was punctuated by a collapse of a merger agreement with Albertsons Cos. grocery chain, sinking the shares over 9% on Thursday to $1.58 per share.

  • Rite Aid Stock Plunges on Collapse of Albertsons Merger
    InvestorPlace5 days ago

    Rite Aid Stock Plunges on Collapse of Albertsons Merger

    Rite Aid notes that the reason it is no longer moving forward with the merger is due to the views of its shareholders. Rite Aid also points out that the agreement between it and Albertsons doesn’t require a payment from either company for the cancellation of the merger agreement. “We will continue building momentum for key areas of our business like our innovative Wellness store format, highly successful customer loyalty program and expanded pharmacy service offerings, as we also enhance our omni-channel and own brand offerings to strengthen our competitive position and create long-term value for stockholders,” Rite Aid Chairman and CEO John Standley said in a statement.

  • Here’s Why Wall Street Has Turned Bearish on Walgreens
    Market Realist5 days ago

    Here’s Why Wall Street Has Turned Bearish on Walgreens

    Amazon’s (AMZN) acquisition of PillPack and the fears of rising competition resulted in a series of Wall Street downgrades of Walgreens Boots Alliance (WBA). Three analysts downgraded their ratings on the drug store giant in June, and another three downgraded the stock in July.

  • CVS Health Beats on Q2 2018 Top and Bottom Lines
    Market Realist5 days ago

    CVS Health Beats on Q2 2018 Top and Bottom Lines

    CVS Health (CVS) reported its second-quarter earnings results on August 8. The pharmacy giant reported better-than-expected top and bottom line results during the quarter.

  • Investopedia5 days ago

    The Top 5 Rite Aid Shareholders

    Learn about the top five major direct shareholders of Rite Aid Corporation, and learn about these shareholders' positions in Rite Aid and their backgrounds.

  • Walgreens’s Stock Performance This Year: The Ups and Downs
    Market Realist5 days ago

    Walgreens’s Stock Performance This Year: The Ups and Downs

    Walgreens Boots Alliance (WBA) stock has been in the red almost throughout the whole year so far. Interestingly, the pharmacy giant’s stock performance hasn’t been driven by its own financial performance, but by Amazon’s expansion plans in the pharma space. Walgreens has reported quarterly results for the first three fiscal quarters of 2018 this year.

  • Benzinga5 days ago

    Benzinga Pro's 5 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Booking Holdings Inc (NASDAQ: BKNG ) stock was trading ...

  • Walgreens Boots Alliance: The Good News and the Bad News
    Market Realist5 days ago

    Walgreens Boots Alliance: The Good News and the Bad News

    Walgreens Boots Alliance (WBA), America’s second-largest pharmacy chain and a recent addition to the Dow Jones Index, has been going strong for years. The company has grown its top line at a CAGR (compound annual growth rate) of 11% over the last five years. While the company has taken the organic as well as the inorganic route to boost sales, earnings growth has been a result of improving profitability and a solid stock repurchase plan.

  • Investopedia5 days ago

    Rite Aid, Albertsons $24B Deal to Fight Amazon Scrapped

    Rite Aid Corp. ( RAD) and Albertsons have agreed to call off their multibillion-dollar merger after failing to convince investors that joining forces would leave them better equipped to tackle growing competition from Amazon.com Inc. ( AMZN) and others. “While we believed in the merits of the combination with Albertsons, we have heard the views expressed by our stockholders and are committed to moving forward and executing our strategic plan as a stand-alone company,” said Rite Aid’s CEO John T. Standley in a statement. Rite Aid’s shares have fallen about 22% since Albertsons' offer was first announced in February, reflecting concerns that the grocery firm’s bid undervalued the drugstore chain.

  • See what the IHS Markit Score report has to say about Walgreens Boots Alliance Inc.
    Markit6 days ago

    See what the IHS Markit Score report has to say about Walgreens Boots Alliance Inc.

    Short interest is low for WBA with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding WBA is favorable, with net inflows of $20.49 billion.

  • CNBC6 days ago

    CVS dives deeper into medical services, offering up virtual visits through Teladoc

    The drugstore chain plans to make video visits available nationwide by the end of the year through a partnership with Teladoc Health. CVS already offers virtual appointments, branded as MinuteClinic Video Visits, in nine states and the District of Columbia.

  • 'Ultimately, Elizabeth made the decisions': A look inside Theranos' ineffective board
    American City Business Journals6 days ago

    'Ultimately, Elizabeth made the decisions': A look inside Theranos' ineffective board

    Court documents give some insight into one of the biggest questions about Theranos: How could its board stand pat as key employees left and allegations emerged about the blood testing company's technology?

  • Buy Amazon (AMZN) Stock On Possible Gas Station & Travel Push?
    Zacks7 days ago

    Buy Amazon (AMZN) Stock On Possible Gas Station & Travel Push?

    Shares of Amazon (AMZN) popped Tuesday after D.A. Davidson analysts suggested that the next logical industries for the e-commerce giant to enter would be gas stations and travel. Amazon could likely jump into the gas station market without much fuss, similar to Costco (COST), and certainly has the online infrastructure and customer base to offer travel deals. But what should investors make of this?

  • Advent Has Held Talks to Sell Pharmacy Company Genoa
    Bloomberg7 days ago

    Advent Has Held Talks to Sell Pharmacy Company Genoa

    Private-equity firm Advent International has held talks with potential buyers about selling pharmacy company Genoa Healthcare, according to people familiar with the matter. Genoa, which could be worth about $2.5 billion in a sale, has attracted interest from drugstore chain Walgreens Boots Alliance Inc., among other suitors, said the people, who asked not to be identified because the details aren’t public. Genoa operates more than 400 full-service pharmacies within community mental-health centers in the U.S., and serves about 650,000 customers, according to a company fact sheet.

  • How Compelling Are CVS Health’s Valuations?
    Market Realist7 days ago

    How Compelling Are CVS Health’s Valuations?

    CVS Health (CVS) is currently trading at 9.1x its NTM (next-12-months) earnings of $7.02. WBA is currently trading at a forward PE multiple of 10.6x versus a three-year average of 15.5x. CVS Health’s earnings are projected to grow 12.6% over the next 12 months by Wall Street.

  • CVS Health’s Analyst Ratings Have Improved in 2018
    Market Realist7 days ago

    CVS Health’s Analyst Ratings Have Improved in 2018

    CVS Health (CVS) is a well-covered stock and is tracked by 23 Wall Street analysts. The company is rated a 1.9 on a scale of 1 (strong buy) to 5 (strong sell). The company was also upgraded by Needham (from “buy” to “strong buy”), Morgan Stanley (from “equal-weight” to “overweight”), and Raymond James (from “outperform” to “strong buy”) early this year.

  • Investor's Business Daily8 days ago

    Rite Aid's Drug Market Warning Sinks Stock Ahead Of Buyout Vote

    Rite Aid plunged after the drugstore chain lopped its annual profit outlook, citing headwinds from the generic drug market for the rest of this year.

  • What Has Subdued CVS Health’s Stock Price in 2018?
    Market Realist8 days ago

    What Has Subdued CVS Health’s Stock Price in 2018?

    Competitor Walgreens Boots Alliance (WBA) has also fallen 7.8% so far this year. Amazon’s (AMZN) foray into the pharma space with the PillPack acquisition, and the ongoing uncertainty arising from the Trump administration’s recommendations on how PBMs would receive rebates, has impacted drugstore stocks adversely. Amazon’s acquisition announcement of PillPack on June 28 resulted in respective declines of 6.0% and 9.0% in the stock prices of CVS Health and Walgreens.